Dr Kate Absolom

BSc (Hons) Psychology, PhD Psychology

University Academic Fellow

Phone: 0113 2068952

Email: k.l.absolom@leeds.ac.uk

I am an applied health researcher with a background in social science. A core focus of my research has been developing and evaluating digital approaches in patient reported assessment for both understanding patient outcomes and enhancing cancer care. I co-lead the Patient Centred Outcomes Research (PCOR) group within Leeds Institute of Medical Research (LIMR) and also work within the Division of Health Services Research in the Leeds Institute of Health Sciences (LIHS).

I am experienced in a range of methodological approaches including the design and delivery of studies that combine qualitative and quantitative techniques in observational and trial settings. The increasing recognition of the value of patient reported outcomes measures (PROMs) in health care has led to growing research interest in this field and means I collaborate with experts across clinical teams and backgrounds (including statistics, epidemiology, computing, informatics and commercial digital companies). Through these collaborations I have become interested in the use of larger scale patient data to understand the impact of cancer and treatments on future outcomes. An important aspect of this is understanding how health professionals, patients and the public perceive and understand the use patient reported and wider routine clinical and administration data in research.

Over the past few years, I have been a member of the Yorkshire based components of National Institute for Health and Care Research (NIHR) Research Design Service (RDS), now reformed as the Research Support Service (RSS), where I provide advice to clients preparing research and fellowship funding applications.

Previously I studied psychology at Lancaster University and completed a PhD at the University of Sheffield in 2005. My doctoral research, funded by Cancer Research UK, evaluated models of follow-up care for people treated for cancer in childhood. Before joining the University of Leeds I held a postdoctoral position with the Late Effects Group, Sheffield where I contributed to a number of studies focussed on the impact of cancer on the lives of younger adults.

Research interests

  • Understanding the psychosocial impact of cancer and treatment on patients and families.
  • Evaluating and implementing the routine use of patient reported outcome measures (PROMs) in cancer.
  • The application of patient centred digital technology to support cancer care and clinical pathways.
  • Patient and public engagement in research (including patient and public perspectives of the use of patient reported and routine health/administration data.

Selected research grants

  • Does intensive multidisciplinary team intervention improve bowel cancer outcomes in Yorkshire (Bowel Cancer Improvement programme, BCIP). Funded by Yorkshire Cancer Research (Co-I) https://ycrbcip.leeds.ac.uk/
  • MyPath: Developing and implementing innovative Patient-Centred Care Pathways for cancer patients Funded by Horizon Europe/UKRI: (Co-I) https://mypath-cancercare.eu/  
  • Understanding, interpreting and sharing patient reported data: Further in-depth analysis and visualisation of cancer symptom profiles from the eRAPID programme: Funded by National Institute for Health and Care Research (NIHR) Programme Development Grant (Co-PI) https://fundingawards.nihr.ac.uk/award/NIHR202959   

Current PhD/DClin supervision

  • Ruth Evans: Trustworthy communication of data-driven clinical recommendations
  • Zuzanna Wojcik: Predicting Hospital Utilisation and Chemotherapy Management from Cancer Patient-Reported Outcome Measures
  • Eme Asuquo: Living with and beyond breast cancer among women in Nigeria: a mixed methods study
  • Sarah Milner: The social outcomes of childhood cancer survivors
  • Darci Tillbrook: Uncovering the invisible labour that patients and families undertake to support the safety and quality of breast cancer care during the COVID-19 pandemic
  • Victoria Robins: Physical functioning after treatment for breast cancer and the impact of age
  • Ellen Tomlinson: (DClin): Exploring the relationship between self-compassion and burnout among UK oncology nurses

Past PhD supervision (completed)

  • Dr Chris Bedding: Improving health-related quality of life in metastatic breast cancer. Taking stock of achievements and delivering better measurement (2023)
  • Sarah Rudkin (DClin): The experience of interval scans for adults living with primary malignant brain tumours (2022)
  • Dr Kathleen Kane: Living better with advanced breast cancer (LIBERATE); Symptom-reporting, self-management and sign-posting support for secondary breast cancer (2021)
  • Dr Cecilia Pompili: Early stage non-small cell lung cancer’s treatment journey : patients’ perspectives (2019)
  • Dr Lorraine Warrington: Routine self-reporting of symptoms and side effects during cancer treatment : the patient’s perspective (2018)
  • Dr Elena Takeuchi: Role of patient-reported symptoms and functioning in the care of patients with metastatic colorectal cancer (2016)

Qualifications

  • PhD Follow-up care for survivors of childhood cancer, University of Sheffield, 2006
  • BSc (Hons) Psychology, Lancaster University 2000

Professional memberships

  • Fellow of the Higher Education Academy (FHEA)
  • National Institute for Health and Care Research (NIHR) Methodology Incubator Member of Health Data Science work stream (2022-present)
  • British Psychosocial Oncology Society (BPOS). Current member and Past Chair (2019-2022)
  • International Society for Quality of Life Research (ISOQOL). Current member and Past Co-Chair Clinical Practice Special Interest Group (2018-2020)
  • MRC-NIHR Trial Methodology Research Partnership Outcomes Working Group (2022-present)

Papers

Robins VR, Gelcich S, Absolom K, Velikova G. 2024. The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: A systematic review. The Breast. 103734-103734 76  

Absolom K, Rogers Z, Catto J, Bottomley S, Glaser A, Downing A. 2024. Decision regret regarding treatment choices one year after a new diagnosis of bladder cancer. European Urology. 

Dawkins B, Absolom K, Hewison J, Warrington L, Hudson E, Holch P, Carter R, Gibson A, Holmes M, Rogers Z, Dickinson S, Morris C, Woroncow B, Brown J, Hulme C, Velikova G. 2024. Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy. JCO Oncology Practice. 581-590 20.4  

Rogers Z, Glaser A, Catto JWF, Bottomley S, Jubber I, Kotwal S, Brittain P, Gill J, Rogers MA, Dooldeniya MD, Koenig P, Cresswell J, Chahal R, Bryan N, Smith NJ, Pritchard K, Abbasi Z, Mason SJ, Absolom K, Downing A. 2024. Health‐related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year. BJU International. 460-473 133.4  

Asuquo E, Absolom K, Ebenso B, Allsop M. 2024. Symptoms, concerns, and experiences of women living with and beyond breast cancer in Africa: A mixed-methods systematic review. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer. 

Wójcik Z, Dimitrova V, Warrington L, Velikova G, Absolom K, Wojcik Z. 2024. Using Machine Learning to Predict Unplanned Hospital Utilisation and Chemotherapy Management from Patient-Reported Outcome Measures. JCO Clinical Cancer Informatics. 

Evans RP, Bryant LD, Russell G, Absolom K. 2024. Trust and acceptability of data-driven clinical recommendations in everyday practice: A scoping review. International Journal of Medical Informatics. 105342-105342 183 

Milner SH, Feltbower RG, Absolom KL, Glaser AW. 2024. Identifying social outcomes of importance for childhood cancer survivors: an e-Delphi study. Journal of Patient-Reported Outcomes. 8.1  

Unni E, Coles T, Lavallee DC, Freel J, Roberts N, Absolom K. 2024. Patient adherence to patient-reported outcome measure (PROM) completion in clinical care: current understanding and future recommendations. QUALITY OF LIFE RESEARCH. 281-290 33.1  

Holch P, Turner G, Keetharuth AD, Gibbons E, Cocks K, Absolom KL. 2023. The impact of COVID-19 on PRO development, collection and implementation: views of UK and Ireland professionals. Journal of Patient-Reported Outcomes. 7.1  

Spencer K, Absolom K, Allsop M, Relton S, Pearce J, Liao K, Naseer S, Salako O, Howdon D, Hewison J, Velikova G, Faivre-Finn C, Bekker H, van der Veer S. 2023. Fixing the leaky pipe: how to improve the uptake of patient reported outcomes-based prognostic and predictive models in cancer clinical practice. JCO Clinical Cancer Informatics. 

Boele FW, Rudkin SE, Absolom K, Latchford G, Short SC, Booth TC. 2023. The experience of interval scans for adults living with primary malignant brain tumors. Supportive Care in Cancer. 31.6  

Catto JWF, Rogers Z, Downing A, Mason SJ, Jubber I, Bottomley S, Conner M, Absolom K, Glaser A. 2023. Lifestyle Factors in Patients with Bladder Cancer: A Contemporary Picture of Tobacco Smoking, Electronic Cigarette Use, Body Mass Index, and Levels of Physical Activity. European Urology Focus.  

Holch P, Absolom KL, Henry AM, Walker K, Gibson A, Hudson E, Rogers Z, Holmes M, Peacock R, Pini S, Gilbert A, Davidson S, Routledge J, Murphy A, Franks K, Hulme C, Hewison J, Morris C, McParland L, Brown J, Velikova G. 2023. Online symptom monitoring during pelvic radiotherapy: randomised pilot trial of eRAPID intervention. International Journal of Radiation: Oncology – Biology – Physics. 664-676 115.3  

Tillbrook D, Absolom K, Sheard L, Baxter R, O’Hara JK. 2022. What Do Patients and Their Carers Do to Support the Safety of Cancer Treatment and Care? A Scoping Review. Journal of Patient Safety. 779-787 18.8  

Milner S, Feltbower RG, Absolom K, Glaser A. 2022. Identifying the important social outcomes for childhood cancer survivors: an e-Delphi study protocol. BMJ Open. e063172-e063172 12.11 

Taylor JC, Iversen LH, Burke D, Finan PJ, Iles MM, Morris EJA, Quirke P, YCR BCIP Study Group. 2022. Differences in the management of patients requiring an emergency resection for colonic cancer in two European populations. BJS Open. 6.5  

Jubber I, Rogers Z, Catto JWF, Bottomley S, Glaser A, Downing A, Absolom K. 2022. Sexual Activity, Function and Dysfunction After a Diagnosis of Bladder Cancer. The Journal of Sexual Medicine. 1431-1441 19.9  

Pompili C, Dalmia S, McLennan Battleday F, Rogers Z, Absolom K, Bekker H, Franks K, Brunelli A, Velikova G. 2022. Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 2447-2454 148.9  

Dalmia S, Boele F, Absolom K, Brunelli A, Franks K, Bekker HL, Pompili C. 2022. Shared decision-making in early stage non-small cell lung cancer: A systematic review. The Annals of Thoracic Surgery. 581-590 114.2  

Stamp E, Clarke G, Wright P, Velikova G, Crossfield SSR, Zucker K, McInerney C, Bojke C, Martin A, Baxter P, Woroncow B, Wilson D, Warrington L, Absolom K, Burke D, Stables GI, Mitra A, Hutson R, Glaser AW, Hall G. 2022. Collection of cancer Patient Reported Outcome Measures (PROMS) to link with primary and secondary electronic care records to understand and improve long term cancer outcomes: A protocol paper. PLoS One. 17.4  

Absolom K. 2022. Psycho‐Oncology 30 years celebrations. Psycho-Oncology. 558-558 31.4 

King L, Matthews S, Foster C, Starkings R, Holch P, Absolom K, Archer S. 2022. ‘A fascinating time to be involved with research’ exploring the impact of COVID‐19 on postgraduate psycho‐oncology researchers. Psycho-Oncology. 671-675 31.4 

Milner SH, Feltbower R, Absolom KL, Glaser A. 2022. Social outcomes after childhood illness: the missing measure. Archives of Disease in Childhood.  

Velikova G, Absolom K, Hewison J, Holch P, Warrington L, Avery K, Richards H, Blazeby J, Dawkins B, Hulme C, Carter R, Glidewell L, Henry A, Franks K, Hall G, Davidson S, Henry K, Morris C, Conner M, McParland L, Walker K, Hudson E, Brown J. 2022. Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs. Programme Grants for Applied Research. 10.1  

Pompili C, Rogers Z, Absolom K, Holch P, Clayton B, Callister M, Robson J, Brunelli A, Franks K, Velikova G. 2021. Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: A longitudinal study. Lung Cancer. 71-78 162  

Taylor JC, Iversen LH, Burke D, Finan PJ, Howell S, Pedersen L, Iles MM, Morris EJA, Quirke P, the YCR BCIP Study Group. 2021. Influence of age on surgical treatment and postoperative outcomes of patients with colorectal cancer in Denmark and Yorkshire, England. Colorectal Disease. 3152-3161 23.12  

Richards HS, Portal A, Absolom K, Blazeby JM, Velikova G, Avery KNL. 2021. Patient experiences of an electronic PRO tailored feedback system for symptom management following upper gastrointestinal cancer surgery. Quality of Life Research. 3229-3239 30.11  

Absolom K, Warrington L, Hudson E, Hewison J, Holch P, Dawkins B, Hulme C, Brown J, Velikova G. 2021. Reply to H. Shojima et al. Journal of Clinical Oncology. 2633-2634 39.23  

Catto JWF, Downing A, Mason S, Wright P, Absolom K, Bottomley S, Hounsome L, Hussain S, Varughese M, Raw C, Kelly P, Glaser AW. 2021. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes. European Urology. 621-632 79.5  

Kane K, Kennedy F, Absolom KL, Harley C, Velikova G. 2021. Quality of life support in advanced cancer – Web and technological interventions: systematic review and narrative synthesis. BMJ Supportive and Palliative Care.  

Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, Carter R, Gibson A, Holmes M, Clayton B, Rogers Z, McParland L, Conner M, Glidewell L, Woroncow B, Dawkins B, Dickinson S, Hulme C, Brown J, Velikova G. 2021. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy. Journal of Clinical Oncology. 734-747 39.7  

Kennedy F, Absolom K, Clayton B, Rogers Z, Gordon K, O’Connell Francischetto E, Blazeby JM, Brown J, Velikova G. 2021. Electronic Patient Reporting of Adverse Events and Quality of Life: A Prospective Feasibility Study in General Oncology. JCO Oncology Practice. e386-e396 17.3  

Stover AM, Schougaard LMV, Absolom K. 2020. Registered Reports: clarifications and opportunities from ISOQOL’S Special Interest Group for Clinical Practice. Quality of Life Research. 3183-3184 29.12 

Pompili C, Boele F, Absolom K, Holch P, Clayton B, Smillye E, Franks K, Velikova G. 2020. Patient views of routine quality of life assessment following a diagnosis of early stage non-small cell lung cancer. Interactive Cardiovascular and Thoracic Surgery. 324-330 31.3  

Archer S, Holch P, Armes J, Calman L, Foster C, Gelcich S, MacLennan SJ, Absolom K. 2020. “No turning back” Psycho‐oncology in the time of COVID‐19: Insights from a survey of UK professionals. Psycho-Oncology. 1430-1435 29.9  

Pompili C, Holch P, Rogers Z, Absolom K, Clayton B, Franks K, Bekker H, Velikova G. 2020. Patients’ confidence in treatment decisions for early stage non-small cell lung cancer (NSCLC). Health and Quality of Life Outcomes. 18.1  

Richards HS, Blazeby JM, Portal A, Harding R, Reed T, Lander T, Chalmers KA, Carter R, Singhal R, Absolom K, Velikova G, Avery KNL. 2020. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery. BMC Cancer. 20.1  

Holch P, Absolom K, Brooke C, Wang X. 2020. Advances in Patient Reported Outcomes: Integration and Innovation. Leeds, UK. 13 June 2019. Journal of Patient-Reported Outcomes. 4.S1  

Avery KNL, Richards HS, Portal A, Reed T, Harding R, Carter R, Bamforth L, Absolom K, O’Connell Francischetto E, Velikova G, Blazeby JM. 2019. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery. BMC Cancer. 19  

Absolom K, Gibson A, Velikova G. 2019. Engaging patients and clinicians in online reporting of adverse effects during chemotherapy for cancer. The eRAPID system (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice). Medical Care. s59-s65 57.5 Supplement 1  

Warrington L, Absolom K, Conner M, Kellar I, Clayton B, Ayres M, Velikova G. 2019. Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review (Preprint). Journal of Medical Internet Research. 

Warrington L, Absolom K, Conner M, Kellar I, Clayton B, Ayres M, Velikova G. 2019. Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review. Journal of Medical Internet Research. 21.1  

Pompili C, Absolom K, Franks K, Velikova G. 2018. Are quality of life outcomes comparable following stereotactic radiotherapy and minimally invasive surgery for stage I lung cancer patients?. Journal of Thoracic Disease. 7055-7063 10.12  

Young AL, Lee E, Absolom K, Baxter H, Christophi C, Lodge JPA, Glaser AG, Toogood GJ. 2018. Expectations of outcomes in patients with colorectal cancer. BJS Open. 285-292 2.5  

Pompili C, Koller M, Velikova G, Franks K, Absolom K, Callister M, Robson J, Imperatori A, Brunelli A. 2018. EORTC QLQ-C30 summary score reliably detects changes in QoL three months after anatomic lung resection for Non-Small Cell Lung Cancer (NSCLC). Lung Cancer. 149-154 123  

Taarnhøj GA, Kennedy FR, Absolom KL, Bæksted C, Vogelius IR, Johansen C, Velikova G, Pappot H. 2018. Comparison of EORTC QLQ-C30 and PRO-CTCAE™ questionnaires on six symptom items. Journal of Pain and Symptom Management. 421-429 56.3  

Holch P, Pini S, Henry AM, Davidson S, Routledge J, Brown J, Absolom K, Gilbert A, Franks K, Hulme C, Morris C, Velikova G. 2018. eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy. Pilot and Feasibility Studies. 4

Pompili C, Absolom K, Velikova G, Backhus L. Patients reported outcomes in thoracic surgery. Journal of Thoracic Disease. 2018; 10 (2):703-706.
21037/jtd.2018.01.140
View Open Access version

Absolom K, Holch P, Amir Z. Introduction to special section on digital technology and cancer survivorship.. Journal of Cancer Survivorship. 2017; 11 (6):655-657.
1007/s11764-017-0644-x
 View Open Access version

Young AL, Rowe IA, Absolom K, Jones RL, Downing A, Meader N, Glaser A, Toogood GJ. The effect of Liver Transplantation on the quality of life of the recipient’s main caregiver – a systematic review. Liver International. 2017; 37 (6):794-801.
1111/liv.13333
View Open Access version

Absolom K, Holch P, Warrington L, Samy F, Hulme C, Hewison J, Morris C, Bamforth L, Conner M, Brown J, Velikova G. Electronic patient self-Reporting of adverse-events: Patient information and advice (eRAPID): A randomised controlled trial in systemic cancer treatment. BMC Cancer. 2017; 17 (1):-.
1186/s12885-017-3303-8
View Open Access version

Holch P, Warrington L, Bamforth LCA, Keding A, Ziegler LE, Absolom K, Hector C, Harley C, Johnson O, Hall G, Morris C, Velikova G. Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment. Annals of Oncology. 2017; 28 (9):2305-2311.
1093/annonc/mdx317
View Open Access version

Holch P, Warrington L, Potrata B, Ziegler L, Hector C, Keding A, Harley C, Absolom K, Morris C, Bamforth L, Velikova G. Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients. Acta Oncologica. 2016; 55 (9-10):1220-1226.
1080/0284186X.2016.1213878
View Open Access version

Taylor S, Harley C, Absolom K, Brown J, Velikova G. Breast Cancer, Sexuality, and Intimacy: Addressing the Unmet Need. Breast Journal. 2016; 22 (4):478-479.
1111/tbj.12614
View Open Access version

Santana MJ, Haverman L, Absolom K, Takeuchi E, Feeny D, Grootenhuis M, Velikova G. Training clinicians in how to use patient-reported outcome measures in routine clinical practice. Quality of Life Research. 2015; 24 (7):1707-1718.
1007/s11136-014-0903-5
View Open Access version

Warrington L, Absolom K, Velikova G. Integrated care pathways for cancer survivors – A role for patient-reported outcome measures and health informatics. Acta Oncologica. 2015; 54 (5):600-608.
3109/0284186X.2014.995778
View Open Access version

Absolom K, Holch P, Woroncow B, Wright EP, Velikova G. Beyond lip service and box ticking: how effective patient engagement is integral to the development and delivery of patient-reported outcomes. Quality of Life Research. 2015; 24 (5):1077-1085.
1007/s11136-014-0909-z
View Open Access version

Harley C, Takeuchi E, Taylor S, Keding A, Absolom K, Brown J, Velikova G. A mixed methods approach to adapting health-related quality of life measures for use in routine oncology clinical practice. Quality of Life Research. 2012; 21 (3):389-403.
1007/s11136-011-9983-7
View Open Access version

Taylor N, Absolom K, Snowden J, Eiser C. Need for psychological follow-up among young adult survivors of childhood cancer. European Journal of Cancer Care. 2012; 21 (1):52-58.
1111/j.1365-2354.2011.01281.x

Holch P, Absolom K, Pini S, Hill KM, Liu A, Sharpe M, Richardson A, Hosker C, Velikova G. Oncology professionals’ views on the use of antidepressants in cancer patients: a qualitative interview study. BMJ supportive & palliative care. 2011; 1 (3):301-305.
1136/bmjspcare-2011-000076

Arden-Close E, Absolom K, Greenfield DM, Hancock BW, Coleman RE, Eiser C. Gender differences in self-reported late effects, quality of life and satisfaction with clinic in survivors of lymphoma. Psycho-Oncology. 2011; 20 (11):1202-1210.
1002/pon.1835

Michel G, Greenfield D, Absolom K, Eiser C. Satisfaction with follow-up consultations among younger adults treated for cancer: The role of quality of life and psychological variables. Psycho-Oncology. 2011; 20 (8):813-822.
1002/pon.1783

Absolom K, Holch P, Pini S, Hill K, Liu A, Sharpe M, Richardson A, Velikova G. The detection and management of emotional distress in cancer patients: The views of health-care professionals. Psycho-Oncology. 2011; 20 (6):601-608.
1002/pon.1916

Phillips R, Absolom K, Stark D, Glaser A. A simple practical patient-reported clinic satisfaction measure for young adults. British Journal of Cancer. 2010; 103 (10):1485-1488.
1038/sj.bjc.6605923

Taylor N, Absolom K, Michel G, Urquhart T, Gerrard M, Jenkins A, Lee V, Vora A, Eiser C. Comparison of self-reported late effects with medical records among survivors of childhood cancer. European Journal of Cancer. 2010; 46 (6):1069-1078.
1016/j.ejca.2010.01.022

Michel G, Taylor N, Absolom K, Eiser C. Benefit finding in survivors of childhood cancer and their parents: Further empirical support for the Benefit Finding Scale for Children. Child: Care, Health and Development. 2010; 36 (1):123-129.
1111/j.1365-2214.2009.01034.x

Greenfield DM, Absolom K, Eiser C, Walters SJ, Michel G, Hancock BW, Snowden JA, Coleman RE. Follow-up care for cancer survivors: The views of clinicians. British Journal of Cancer. 2009; 101 (4):568-574.
1038/sj.bjc.6605160

Absolom K, Eiser C, Michel G, Walters SJ, Hancock BW, Coleman RE, Snowden JA, Greenfield DM. Follow-up care for cancer survivors: Views of the younger adult. British Journal of Cancer. 2009; 101 (4):561-567.
1038/sj.bjc.6605213

Michel G, Greenfield DM, Absolom K, Ross RJ, Davies H, Eiser C. Follow-up care after childhood cancer: Survivors’ expectations and preferences for care. European Journal of Cancer. 2009; 45 (9):1616-1623.
1016/j.ejca.2009.02.026

Absolom K, Eiser C, Turner L, Ledger W, Ross R, Davies H, Coleman R, Hancock B, Snowden J, Greenfield D. Ovarian failure following cancer treatment: Current management and quality of life. Human Reproduction. 2008; 23 (11):2506-2512.
1093/humrep/den285

Absolom K, Greenfield D, Ross R, Davies H, Hancock B, Eiser C. Reassurance following breast screening recall for female survivors of Hodgkin’s lymphoma. Breast. 2007; 16 (6):590-596.
1016/j.breast.2007.05.001

Eiser C, Absolom K, Greenfield D, Snowden J, Coleman R, Hancock B, Davies H. Follow-up care for young adult survivors of cancer: Lessons from pediatrics. Journal of Cancer Survivorship. 2007; 1 (1):75-86.
1007/s11764-007-0006-1

Eiser C, Absolom K, Greenfield D, Glaser A, Horne B, Waite H, Urquhart T, Wallace WHB, Ross R, Davies H. Follow-up after childhood cancer: Evaluation of a three-level model. European Journal of Cancer. 2006; 42 (18):3186-3190.
1016/j.ejca.2006.08.001

Absolom K, Greenfield D, Ross R, Horne B, Davies H, Glaser A, Simpson A, Waite H, Eiser C. Predictors of clinic satisfaction among adult survivors of childhood cancer. European Journal of Cancer. 2006; 42 (10):1421-1427.
1016/j.ejca.2006.01.053

Absolom K, Eiser C, Greco V, Davies H. Health promotion for survivors of childhood cancer: A minimal intervention. Patient Education and Counseling. 2004; 55 (3):379-384.
1016/j.pec.2003.04.007

Absolom K, Takeuchi E, Hall G, Velikova G. Psychological aspects of hereditary and non-hereditary ovarian cancer. Advances in Diagnosis and Management of Ovarian Cancer. 2014. p. 223-239.
1007/978-1-4614-8271-0_13